Douglas R. Galasko, MD
Affiliations: | Neuroscience | University of California, San Diego, La Jolla, CA |
Area:
DementiaWebsite:
http://neurograd.ucsd.edu/faculty/detail.php?id=30Google:
"Douglas Galasko"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=73
http://ucsd.photobooks.com/directory/profile.asp?setsize=10000&dbase=main&pict_id=0001460
Mean distance: 19.84 (cluster 32)
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Tsiknia AA, Sundermann EE, Reas ET, et al. (2022) Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity. Alzheimer's Research & Therapy. 14: 160 |
Caldwell AB, Anantharaman BG, Ramachandran S, et al. (2022) Transcriptomic profiling of sporadic Alzheimer's disease patients. Molecular Brain. 15: 83 |
Salmon DP, Smirnov DS, Coughlin DG, et al. (2022) Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease. Neurology |
Gollan TH, Stasenko A, Li C, et al. (2022) Autocorrection if→of function words in reading aloud: A novel marker of Alzheimer's risk. Neuropsychology |
Tian C, Stewart T, Hong Z, et al. (2022) Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Tsiknia AA, Edland SD, Sundermann EE, et al. (2022) Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Molecular Psychiatry |
Mozersky J, Roberts SJ, Rumbaugh M, et al. (2022) Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants. Journal of Alzheimer's Disease : Jad |
Bernier RA, Banks SJ, Panizzon MS, et al. (2022) The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12284 |
Smirnov D, Galasko D. (2022) Dynamics of neuroinflammation in Alzheimer's disease. The Lancet. Neurology. 21: 297-298 |
Smirnov DS, Ashton NJ, Blennow K, et al. (2022) Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change. Acta Neuropathologica |